Homepage
Medication Guide
Indications of Sirolimus Albumin (Fyarro)
Sirolimus Albumin (Fyarro) is a novel antineoplastic agent specifically indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioi...
502
Tuesday, September 9th, 2025, 16:10
What Kind of Drug Is Dificid (Fidaxomicin)?
Dificid (fidaxomicin) is a macrolide antibacterial drug developed by Merck & Co., Inc. It was approved for marketing by the U.S. FDA in 2011. As a narrow-spectrum antibacterial agent, fidaxomicin ...
501
Tuesday, September 9th, 2025, 16:03
Indications of ExtraSuperTadarise
ExtraSuperTadarise is a combination preparation mainly used for the treatment of erectile dysfunction (ED) and premature ejaculation (PE) in men.Indications of ExtraSuperTadariseCore IndicationsErecti...
501
Tuesday, September 9th, 2025, 16:00
What Are the Side Effects of Trientine (Curior)?
Trientine (Cuvrior) is a copper chelator primarily used for the treatment of adult patients with stable Wilson's disease who have achieved copper excretion and are tolerant to penicillamine. Its m...
502
Tuesday, September 9th, 2025, 15:29
Indications of Trientine (Curior)
Trientine (Curior) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with stable Wilson's disease, and is particularly s...
501
Tuesday, September 9th, 2025, 15:26
How to Use Trientine (CUVRIOR)
Trientine (CUVRIOR) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with Wilson's disease who have achieved copper dep...
502
Tuesday, September 9th, 2025, 13:32
Precautions for Dacomitinib
It is of great importance for both patients and doctors to understand the precautions before using dacomitinib (Vizimpro). Dacomitinib is an oral targeted therapeutic drug, commonly used in the treatm...
501
Monday, September 8th, 2025, 17:01
Dacomitinib: Clinical Uses, Recommended Dosage, Potential Side Effects
Dacomitinib is an oral tyrosine kinase inhibitor primarily used as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR gene mutations. EGFR, ...
501
Monday, September 8th, 2025, 16:56
How to Buy Dacomitinib at a Lower Cost
Dacomitinib, with the English name Dacomitinib, is originally developed by Pfizer Inc. of the United States. It is a highly effective drug for the treatment of metastatic non-small cell lung cancer (N...
501
Monday, September 8th, 2025, 16:44
What is the Price of Dacomitinib?
Dacomitinib is a second-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that has demonstrated significant efficacy in the treatment of EGFR mutation-positive...
502
Monday, September 8th, 2025, 16:36
2 / 85
849 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved